Review: taking Excedrin and Vyvanse together


Summary

Drug interactions are reported among people who take Excedrin and Vyvanse together. This review analyzes the effectiveness and drug interactions between Excedrin and Vyvanse. It is created by eHealthMe based on reports of 16 people who take the same drugs from FDA and social media, and is updated regularly.

You are not alone

Join a support group for people who take Excedrin and Vyvanse >>>

Personalized health information

On eHealthMe you can find out what patients like me (same gender, age) reported their drugs and conditions on FDA and social media since 1977. Our tools are free and anonymous. 86 million people have used us. 300+ peer-reviewed medical journals have referenced our original studies. Start now >>>


Excedrin

Excedrin has active ingredients of acetaminophen; aspirin; caffeine. It is often used in headache. (latest outcomes from Excedrin 8,156 users)

Vyvanse

Vyvanse has active ingredients of lisdexamfetamine dimesylate. It is often used in attention deficit hyperactivity disorder. (latest outcomes from Vyvanse 7,909 users)

On Jul, 27, 2016

16 people who take Excedrin, Vyvanse are studied.


Number of reports submitted per year:

Excedrin and Vyvanse drug interactions.

Drug effectiveness over time:

Excedrin:
  • < 1 month: 0.0% - (0 of 0 people)
  • 1 - 6 months: 0.0% - (0 of 0 people)
  • 6 - 12 months: 0.0% - (0 of 0 people)
  • 1 - 2 years: 100.0% - (6 of 6 people)
  • 2 - 5 years: 100.0% - (4 of 4 people)
  • 5 - 10 years: 0.0% - (0 of 0 people)
  • 10+ years: 100.0% - (1 of 1 people)
  • not specified: 100.0% - (1 of 1 people)
Vyvanse:
  • < 1 month: 100.0% - (1 of 1 people)
  • 1 - 6 months: 0.0% - (0 of 0 people)
  • 6 - 12 months: 0.0% - (0 of 0 people)
  • 1 - 2 years: 0.0% - (0 of 10 people)
  • 2 - 5 years: 0.0% - (0 of 1 people)
  • 5 - 10 years: 0.0% - (0 of 0 people)
  • 10+ years: 0.0% - (0 of 0 people)
  • not specified: 0.0% - (0 of 0 people)

Drug effectiveness by gender:

Excedrin:
  • female: 100.0% - (12 of 12 people)
  • male: 0.0% - (0 of 0 people)
Vyvanse:
  • female: 8.0% - (1 of 12 people)
  • male: 0.0% - (0 of 0 people)

Drug effectiveness by age:

Excedrin:
  • 0-1: 0.0% - (0 of 0 people)
  • 2-9: 0.0% - (0 of 0 people)
  • 10-19: 0.0% - (0 of 0 people)
  • 20-29: 100.0% - (1 of 1 people)
  • 30-39: 0.0% - (0 of 0 people)
  • 40-49: 0.0% - (0 of 0 people)
  • 50-59: 100.0% - (11 of 11 people)
  • 60+: 0.0% - (0 of 0 people)
Vyvanse:
  • 0-1: 0.0% - (0 of 0 people)
  • 2-9: 0.0% - (0 of 0 people)
  • 10-19: 0.0% - (0 of 0 people)
  • 20-29: 100.0% - (1 of 1 people)
  • 30-39: 0.0% - (0 of 0 people)
  • 40-49: 0.0% - (0 of 0 people)
  • 50-59: 0.0% - (0 of 11 people)
  • 60+: 0.0% - (0 of 0 people)

Most common drug interactions over time *:

< 1 month:
  • anxiety
  • coeliac disease
  • drug effect increased
  • headache
  • sleeplessness
  • teeth clinching
1 - 6 months:
  • anxiety
1 - 2 years:
  • fatigue
  • joint pain
  • metallic taste
  • pain in jaw
  • spondylolisthesis acquired
  • thirst
  • cervical spinal stenosis
  • dry eyes
2 - 5 years:
  • cervical spinal stenosis
  • dry eyes
  • fatigue
  • joint pain
  • metallic taste
  • pain in jaw
  • spondylolisthesis acquired
  • thirst
not specified:
  • numbness and tingling
  • sensation of foreign body
  • anxiety
  • coeliac disease
  • drug effect increased
  • headache
  • sleeplessness
  • teeth clinching

Most common drug interactions by gender *:

female:
  • cervical spinal stenosis
  • coeliac disease
  • dry eyes
  • fatigue
  • joint pain
  • metallic taste
  • pain in jaw
  • spondylolisthesis acquired
  • thirst
  • anxiety
male:
  • anxiety

Most common drug interactions by age *:

20-29:
  • anxiety
  • headache
  • numbness and tingling
  • sensation of foreign body
  • sleeplessness
  • teeth clinching
40-49:
  • coeliac disease
  • drug effect increased
50-59:
  • cervical spinal stenosis
  • dry eyes
  • fatigue
  • joint pain
  • metallic taste
  • pain in jaw
  • spondylolisthesis acquired
  • thirst

* Approximation only. Some reports may have incomplete information.

How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.

Do you take Excedrin and Vyvanse?

Can you answer these questions?

More questions for: Excedrin, Vyvanse

You may be interested in these reviews

More reviews for: Excedrin, Vyvanse

On eHealthMe, Excedrin (acetaminophen; aspirin; caffeine) is often used to treat headache. Vyvanse (lisdexamfetamine dimesylate) is often used to treat attention deficit hyperactivity disorder. Find out below the conditions the drugs are used for and how effective they are.

What is the drug used for and how effecitve is it:


NOTE: The study is based on active ingredients and brand name. Other drugs that have the same active ingredients (e.g. generic drugs) are NOT considered.

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

You may report adverse side effects to the FDA at http://www.fda.gov/medwatch/ or 1-800-FDA-1088 (1-800-332-1088).

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.